Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 3Lung Neoplasms 2Pulmonary Disease, Chronic Obstructive 1Obesity 1Insulin Resistance 1Disease 1Diabetes Mellitus, Type 2 1

Interventions

Metformin 139Clomiphene 44Letrozole 36Inositol 27Folic Acid 17Exercise 17Progesterone 16Ethinyl Estradiol 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Chorionic Gonadotropin 10Triptorelin Pamoate 9Tablets 9Spironolactone 8Diet 8Cholecalciferol 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Menotropins 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7drospirenone 6Ovidrel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Polycystic Ovary Syndrome × Sodium-Glucose Transporter 2 Inhibitors × Clear all
NCT05966792 2026-04-13

SGLT2 Inhibitors in Treating Patients With PCOS

Shanghai 10th People's Hospital

Phase NA Completed
82 enrolled

Polycystic Ovary Syndrome

NCT04700839 2022-09-10

PCOS

Shanghai 10th People's Hospital

Phase 4 Completed
68 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡